Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells
Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of HeLa cells
复制标题
Plexin-B1是宫颈癌中miR-214的靶标,促进HeLa细胞的生长和侵袭
DOI:
10.1016/j.biocel.2011.01.002
复制
发表时间:
2011-04-01
影响因子:
4
通讯作者:
Tang, Hua
中科院分区:
文献类型:
--
作者:
Qiang, Ran;Wang, Fang;Tang, Hua
Plexin-B1, the receptor for Sema4D, has been reported to trigger multiple and sometimes opposing cellular responses in various types of tumor cells. It has been implicated in the regulation of tumor-cell survival, proliferation, angiogenesis, invasion and metastasis. However, the plexin-B1 gene expression and its regulatory mechanism in cervical cancer remain unclear. The present study shows that plexin-B1 is over-expressed in cervical tumor tissues compared to normal cervical tissues by immunohistochemistry. Western blotting and quantitative RT-PCR. The expression of plexin-B1 is significantly associated with cervical tumor metastasis and invasion according to the analysis of the clinicopathologic data. Plexin-B1 also promotes proliferation, migration and invasion in human cervical cancer HeLa cells. We also found that the plexin-B1 levels are inversely correlated with miR-214 amounts in both cervical cancer tissues and HeLa cells. And miR-214 expression level is also associated with metastasis and invasion of cervical tumor. Furthermore, we demonstrate that plexin-B1 is inhibited by miR-214 through a miR-214 binding site within the 3'UTR of plexin-B1 in HeLa cells. Ectopic expression of miR-214 could inhibit the proliferation capacity, migration and invasion ability of HeLa cells. Our findings suggest that plexin-B1, a target of miR-214, may function as an oncogene in human cervical cancer HeLa cells. (C) 2011 Elsevier Ltd. All rights reserved.